» Authors » Monika Mrozowska

Monika Mrozowska

Explore the profile of Monika Mrozowska including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 19
Citations 30
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Rusak A, Mrozowska M, Kozlowska W, Wiatrak B, Dziegiel P, Wybraniec S, et al.
Nutrients . 2025 Jan; 16(24. PMID: 39771014
L. (Malabar spinach, Basellaceae), widely consumed as a leafy vegetable, produces dark-colored fruits rich in betacyanins, including rare 6-glycosylated derivatives called gomphrenins. Comprehensive studies on the anti-inflammatory potential of its...
2.
Rusak A, Gasior-Glogowska M, Sargenti A, Krzyzak E, Kotowski K, Mrozowska M, et al.
Pharmacol Rep . 2024 Nov; 77(1):210-228. PMID: 39607670
The protein CHI3L1 contributes to cancer development by several mechanisms, including stimulation of angiogenesis and invasion as well as immunomodulatory effects. These properties make it a potential target for the...
3.
Sochacka-Cwikla A, Regiec A, Czyznikowska Z, Sliwinska-Hill U, Kwiecien A, Wiatrak B, et al.
Bioorg Chem . 2024 Nov; 153:107958. PMID: 39561438
The present study aimed to design and synthesize novel 6-N-benzyloxazolo[5,4-d]pyrimidin-7(6H)-imines 3a-j as possible inhibitors of the vascular endothelial growth factor receptor 2 (VEGFR2). The structures of newly synthesized compounds were...
4.
Olbromski M, Mrozowska M, Smolarz B, Romanowicz H, Rusak A, Piotrowska A
Sci Rep . 2024 Nov; 14(1):26935. PMID: 39505971
Breast cancer (BC) is the leading cause of death among cancer patients worldwide. In 2020, almost 12% of all cancers were diagnosed with BC. Therefore, it is important to search...
5.
Rusak A, Gasior-Glogowska M, Sargenti A, Krzyzak E, Kotowski K, Mrozowska M, et al.
Res Sq . 2024 Oct; PMID: 39399677
Background: (1)The protein CHI3L1 supports cancer development in several ways, including stimulation of angiogenesis and invasion as well as immunomodulatory effects. These properties make it a potential target for the...
6.
Gornicki T, Lambrinow J, Mrozowska M, Krawczynska K, Staszko N, Kmiecik A, et al.
Cells . 2024 Sep; 13(18. PMID: 39329736
Epithelial-to-mesenchymal transition (EMT) is a complex cellular process that allows cells to change their phenotype from epithelial to mesenchymal-like. Type 3 EMT occurs during cancer progression. The aim of this...
7.
Grzeszczuk M, Mrozowska M, Kmiecik A, Rusak A, Jablonska K, Ciesielska U, et al.
In Vivo . 2024 Aug; 38(5):2126-2133. PMID: 39187335
Background/aim: Cardiovascular diseases (CVD) are the leading cause of death worldwide. In 2019, 523 million people were diagnosed with CVD, with 18.6 million deaths. Improved treatment and diagnostics could reduce...
8.
Mrozowska M, Gornicki T, Olbromski M, Partynska A, Dziegiel P, Rusak A
Cancer Med . 2024 Jul; 13(14):e7390. PMID: 39031113
Background: The tetraspanin (TSPAN) family comprises 33 membrane receptors involved in various physiological processes in humans. Tetrasapanins are surface proteins expressed in cells of various organisms. They are localised to...
9.
Olbromski M, Mrozowska M, Piotrowska A, Kmiecik A, Smolarz B, Romanowicz H, et al.
Am J Cancer Res . 2024 Jul; 14(6):3036-3058. PMID: 39005669
Cancer is the leading cause of death worldwide. The World Health Organization (WHO) estimates that 10 million fatalities occurred in 2023. Breast cancer (BC) ranked first among malignancies with 2.26...
10.
Olbromski M, Mrozowska M, Piotrowska A, Smolarz B, Romanowicz H
Cancer Immunol Immunother . 2024 Jun; 73(8):136. PMID: 38833004
A checkpoint protein called the V-domain Ig suppressor of T cell activation (VISTA) is important for controlling immune responses. Immune cells that interact with VISTA have molecules, or receptors, known...